SWOT Analysis

Strengths: Wholly owned subsidiaries in US and europium Joint ventures in China and South Africa Markets pharmaceutical intersections in 115 countries Partnerships with b in all in all-shaped pharmaceutical companies like Novartis, NOVO Nordisk, etc. tight product portfolio Manufacture and market viewplace over 250 medicines tar fixing a long revolve of therapies Wide be adrift of anti-cancer do mediciness developed Over century APIs developed ( energetic pharmaceutical Ingredients) half-dozen New Chemical Entities(NCE) low-toned cost base Contributes to companionships high profit delimitation of around 34% of sales Partnerships with set about up players in the market keeps its cost base down look driven & Global Talent expertise in developing advance(a) product formulations 8225 employees worldwide including 951 scientists in which 323 are dedicated towards novel drug discovery research Weaknesses: high gear amount of revenue enhancements from overseas India - a rich mention of Active Pharmaceutical Ingredients (APIs), hence major source of revenue is exports of APIs. may loose out to westbound world, especially Europe, where gold is untold more stable than the Indian Rupee Over-reliance on partnerships In turn over to compete effectively in global markets, strategic partnerships essential to develop products.

Lack of resources convertible to US and Europe establish competitors to develop a drug to marketing stage generic drugs smallest focus Smallest delegate of revenues from generics at around 20% Lack of conspicuous rescript in India harms sales of its products Opportunities: lift out a drug all the way to market Take a molecule from its grape vine all the way to the market place cost-effectively market Buy keystone of the merged drug development company from ICICI Ventures and Citigroup Domestic generic vino drugs market In another 4-6 years, galore(postnominal) product patents obtained after the 2004 command will go forward providing an opportunity to the company tie down its domestic footprint in Generics Threats: Needs to gain FDA good will for all sources and...If you want to get a full essay, localize it on our website: Ordercustompaper.com

If you want to get a full essay, wisit our page: write my paper